Effect of Prebiotic FOS on Intestinal Abundance of Faecalibacterium Prausnitzii in Patients With Crohn´s Disease
NCT02539849 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38
Last updated 2018-01-31
Summary
FOS improve gut colonization by Faecalibacterium prausnitzii in patients with Crohn's disease
Conditions
- Crohn Disease
Interventions
- DIETARY_SUPPLEMENT
-
FOS
- DRUG
Sponsors & Collaborators
- collaborator INDUSTRY
-
Hospital Universitari Vall d'Hebron Research Institute
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-12-31
- Primary Completion
- 2017-12-19
- Completion
- 2017-12-19
Countries
- Spain
Study Locations
More Related Trials
-
Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis
NCT02488954 ·Status: TERMINATED ·Phase: NA
-
Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease
NCT03266484 ·Status: COMPLETED ·Phase: NA
-
Assessing the Tolerability of Oligosaccharide Supplementation in Patients With Crohn's Disease
NCT02193750 ·Status: TERMINATED ·Phase: NA
-
Treatment With Lactobacillus Rhamnosus and Lactobacillus Acidophilus for Patients With Active Colonic Crohn's Disease.
NCT00374374 ·Status: COMPLETED ·Phase: NA
-
Impact of the Fecal Flora Transplantation on Crohn's Disease
NCT02097797 ·Status: COMPLETED ·Phase: NA
-
Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo
NCT02092389 ·Status: TERMINATED
-
Immune Ablation and Stem Cell Support for Crohn's Disease
NCT00179842 ·Status: WITHDRAWN ·Phase: PHASE2
-
Impact of Anti-Tumor Necrosis Factor (TNF) Antibodies on the T-lymphocyte and Macrophage Cooperation in Crohn Disease
NCT00561548 ·Status: TERMINATED ·Phase: NA
-
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
NCT01861249 ·Status: TERMINATED ·Phase: PHASE2
-
Corporal Composition and Gut Microbiome Modification Through Exclusion Dietary Intervention in Crohn's Disease
NCT06933264 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis
NCT04877990 ·Status: COMPLETED ·Phase: PHASE2
-
Prebiotic Effect on Metabolites in Crohn's Disease
NCT01487759 ·Status: COMPLETED ·Phase: NA
-
Effect of the Consumption of a Probiotic Strain on the Prevention of Post-operative Recurrence in Crohn's Disease
NCT01698970 ·Status: COMPLETED ·Phase: NA
-
R-3750 in Patients With Mild to Moderate Ulcerative Colitis
NCT05666960 ·Status: RECRUITING ·Phase: PHASE1
-
Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)
NCT05817942 ·Status: ACTIVE_NOT_RECRUITING
-
Fecal Transplant for Crohn's Disease
NCT03078803 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease
NCT01235689 ·Status: COMPLETED ·Phase: PHASE3
-
Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease
NCT03395184 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Bifidobacterium Breve Bif195 for Small Intestinal Crohn's Disease
NCT04842149 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Transplantation (FMT) in the Management of Active Crohn's Disease
NCT02199561 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
NCT03105128 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative Colitis
NCT03849599 ·Status: COMPLETED ·Phase: PHASE1
-
Description of Perianal Lesions in a Cohort of Crohn's Disease Patients
NCT02899013 ·Status: COMPLETED
-
Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases
NCT03606499 ·Status: COMPLETED
-
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
NCT01659138 ·Status: TERMINATED ·Phase: PHASE2